Recent Comments

Comment RSS

H1N1 News and Research RSS Feed - H1N1 News and Research Twitter

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

Inovio Biomedical announces positive test results of its consensus influenza vaccines

20. November 2009 06:39
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. [More]

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

20. November 2009 04:19
Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , , , ,

"EurSafety Health-net" launched to fight hospital acquired MRSA infection

20. November 2009 03:34
On November 19, 2009, the kick-off meeting for the Euregio-project "EurSafety Health-net" has taken place. EurSafety Health-net is the follow-up of EUREGIO MRSA-net, that, according to the Robert Koch Institute, gained some sort of model character all over the nation when talking about prevention of hospital acquired MRSA infection. Besides the protection against infection, the main goal of this new project is to strengthen the patients' safety on both sides of the border. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

WSNA highlights serious concerns about safety of nurses and patients during H1N1 pandemic

20. November 2009 01:12
Washington State Nurses Association (WSNA), representing more than 1,600 registered nurses at Sacred Heart Medical Center, is holding a press conference today to highlight serious concerns about the safety of nurses and patients at Sacred Heart Medical Center during this H1N1 pandemic. [More]

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , ,

H1N1: Bridging the knowledge gap

20. November 2009 00:52
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. Infectious diseases specialist Leonard Mermel, DO, medical director of infection control for Rhode Island Hospital, looks at the ongoing debate in light of the H1N1 pandemic, what past research tells us about the spread of influenza, and what is missing in the debate. His commentary is currently available in an online first edition. [More]

CWRU School of Medicine receives grant to fund a Public Health Practice Based Research Network

19. November 2009 23:44
Case Western Reserve University (CWRU) School of Medicine (SOM) has received a Robert Wood Johnson grant to fund a Public Health Practice Based Research Network called The Ohio Research Association for Public Health Improvement (RAPHI). [More]

Posted in: Healthcare News

Tags: , , , ,

High prevalence of asthma among children with H1N1

19. November 2009 22:55
A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. [More]

Posted in: Child Health News | Medical Condition News | Disease/Infection News

Tags: , , , , , , ,

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

19. November 2009 09:35
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic. [More]

Posted in: Drug Trial News | Disease/Infection News

Tags: , , , , , ,

SinoFresh Nasal Spray effective against 'swine flu' in animal study

19. November 2009 07:55
SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 virus. The study data suggests that treatment with SinoFresh allowed the infected animals to recover more rapidly from H1N1 infection than did untreated animals. In addition, pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence of infection. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , ,

First comprehensive, international baseline evidence about pandemics published

19. November 2009 07:30
Public health officials walking a tightrope between massive demand for vaccines and intense public scrutiny of side effects now have a new standard for evaluating the safety of their vaccination programs. [More]

Posted in: Disease/Infection News

Tags: , , , , ,

Exaggerated responses of immune system explain elders’ susceptibility to viral infections

19. November 2009 07:01
Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. Published in the November 19 Cell Host & Microbe, the study bucks the general belief that declining immune responses are to blame for susceptibility to viral infections. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

19. November 2009 06:05
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission. [More]

Posted in: Business / Finance

Tags: , , , ,

Expansion of Excelyte manufacturing plant completed at Midland

19. November 2009 05:29
Integrated Environmental Technologies, Ltd. announces that Benchmark Performance Group, Inc., its exclusive worldwide distributor serving the oil and gas industry, has completed the expansion of its Excelyte® manufacturing plant at its Midland, Texas facility. [More]

Posted in: Miscellaneous News

Tags: , , , , ,

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

19. November 2009 05:04
MMR Information Systems, Inc., and Unis-Tonghe Technology (Zhengzhou) Co., Ltd, announced that they will enter into a definitive agreement by the end of this year to form a joint venture to build a customized version of MMR's proprietary personal health record ("PHR") services (www.mymedicalrecords.com) and professional document imaging and management solutions in China. [More]

Posted in: Business / Finance | Device / Technology News

Tags: , , ,

People with egg allergy can have H1N1 flu vaccine in graded doses

19. November 2009 01:03
As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.